Investors

|

Portal
Order
Home / Research / Publications / The Genomic, Transcriptomic, and Immunological Landscape of Sodium-glucose cotrasporter 2 in Lung Cancer and Association with Clinical Outcomes

Innovation

Publications

Back

The Genomic, Transcriptomic, and Immunological Landscape of Sodium-glucose cotrasporter 2 in Lung Cancer and Association with Clinical Outcomes

– Caris Life Sciences

Poster

Conclusions

  • SLC5A2 expression was associated with a highly altered genomic landscape in AC
  • In specific subgroups, high expression of SLC5A2 was associated with OS and TOT with immunotherapy
Download Publication

Discover
More

  • Optimization of first-line treatment selection in advanced pancreatic adenocarcinoma using artificial intelligence

    – Caris Life Sciences

    Manuscript

    Abstract Improved clinical outcomes are reported for patients with advanced pancreatic adenocarcinoma (PDAC) treated with first-line FOLFIRINOX/NALIRIFOX, but elderly patients with comorbidities are more often… […]

  • Adult Sarcomas with NTRK Fusions: Clinicopathologic and Genomic Heterogeneity

    – Caris Life Sciences

    Manuscript

    Simple Summary Adult sarcomas harboring NTRK fusions are rare and represent a biologically heterogeneous group with diverse morphologic, genomic, and clinical features. In this retrospective… […]
Learn More

Ready to Get Started on the Journey?